Pemigatinib OverviewPemigatinib (INN), sold under the brand name Pemazyre, is a medication for the treatment of adults with previously treated, unresectable locally advanced or metastatic bile duct cancer (cholangiocarcinoma) with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement as detected by an FDA-approved test. Pemigatinib works by blocking FGFR2 in tumor cells to prevent them from growing and spreading. P...
Read more Pemigatinib Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pemigatinib
Recent Pemigatinib Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Tablet: 13.5mg, 4.5mg, 9mg
Other drugs which contain Pemigatinib or a similar ingredient: (1 result)
- PEMAZYRE Pemigatinib